CLINICAL_TRIALS
trial_result
· 2013-01-16
Clinical Trial Update: Celecoxib in Treating Patients With Precancerous Lesions of the Mouth [Phase 2]
Summary
Phase 2 trial evaluating celecoxib for precancerous lesions of the mouth in head and neck cancer patients has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED